Cormorant Asset Management, LP's Form 4 filing
Erasca, Inc.ERAS · filed Dec 20, 2022
- Accession no.
- 0000929638-22-001901
- Filed
- Dec 20, 2022, 5:42 PM ET
- Trade date
- Dec 13, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $2.00M. It was filed 7 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0000929638-22-001904 (Dec 21, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | Director |
| Chen BihuaCIK 0001599214 | Director |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | Director |
| Cormorant Private Healthcare Fund II, LPCIK 0001747677 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | Common Stock | PPurchaseAcquired | +307,692 | $6.50 | +$1,999,998 | 10,813,246 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.